US 10307437
Methods for treatment of vascular endothelial dysfunction using nicotinamide mononucleotide
granted A61KA61K31/706A61P
Quick answer
US patent 10307437 (Methods for treatment of vascular endothelial dysfunction using nicotinamide mononucleotide) held by The Regents of the University of Colorado, a Body Corporate expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/706, A61P, A61P39/00